Shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) traded down 0.6% on Thursday . The company traded as low as $24.49 and last traded at $24.52. 31,676 shares were traded during trading, a decline of 2% from the average session volume of 32,443 shares. The stock had previously closed at $24.67.
iShares Genomics Immunology and Healthcare ETF Stock Performance
The stock has a market capitalization of $143.97 million, a PE ratio of 2.29 and a beta of 1.14. The stock has a 50-day moving average price of $24.54 and a two-hundred day moving average price of $23.94.
iShares Genomics Immunology and Healthcare ETF Company Profile
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Featured Articles
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- Airline Stocks – Top Airline Stocks to Buy Now
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- How to Invest in Blue Chip Stocks
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- What Investors Need to Know About Upcoming IPOs
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
